Background There is considerable literature on the efficacy and safety of various drugs used in treating onychomycosis; however, little information is available regarding prognostic factors which may be associated with non-response to conventional treatment. Objectives To identify parameters influencing mycological cure at 72 weeks following treatment of toenail onychomycosis with oral antifungal agents. Methods Univariate and multivariate logistic regression analysis from a randomized double-blind controlled trial including 496 patients with toenail onychomycosis caused by dermatophytes. Results Baseline parameters including patient's age, gender, weight, number of toenails involved, percentage of nail involvement, duration of infection, history of previous treatment were not associated with mycological cure. In the multivariate prognostic factor analysis based on factors assessed at week 12, positive mycological culture at 12 weeks [odds ratio (OR): 0AE583; 95% confidence interval (CI): 0AE370-0AE918] was negatively associated with mycological cure at 72 weeks. Similarly, in the multivariate prognostic factor analysis based on factors assessed at week 24, positive direct microscopy at 24 weeks (OR: 0AE373; 95% CI: 0AE211-0AE659) and mycological culture at 24 weeks (OR: 0AE293; 95% CI: 0AE168-0AE513) were negatively associated with mycological cure at 72 weeks. Conclusions Mycological culture at 12 and 24 weeks and direct microscopic examination at 24 weeks can help in early identification of patients failing to respond to conventional oral antifungal treatment.
There have been significant changes in the treatment for onychomycosis in the past 10 years. 1 The development of oral antifungal agents effective against dermatophytes and having the ability to concentrate in the nail has made onychomycosis a curable disease. 2 Controlled clinical studies using standard drug regimens have shown that about 50% of onychomycosis patients treated with itraconazole and about 25% of those treated with terbinafine fail to achieve mycological cure following one course of therapy. 3, 4 Recent long-term studies have shown that a more individualized approach is required in such refractory patients who fail to respond to standard drug regimens. 5, 6 Therefore, it would be helpful if difficult to treat patients could be identified early on in order to apply a more tailored treatment approach.
Although there is considerable literature on the efficacy and safety of various drugs used in treating onychomycosis, little information is available regarding prognostic factors which may be associated with nonresponse to conventional treatment. Clinical experience suggests that several host-related factors such as age, nail growth, extent of nail involvement, peripheral vascular disease and type of onychomycosis may affect the chance of cure. [7] [8] [9] [10] However, clinical evidence from a carefully followed-up cohort of onychomycosis patients is lacking. The aim of the present analysis was to investigate host clinical factors associated with mycological cure in patients with onychomycosis treated with oral antifungal agents.
Patients and methods

Study outline
Patients were recruited from a multinational, prospective, randomized, double-blind, double-dummy study comparing the safety and efficacy of continuous terbinafine with intermittent itraconazole in onychomycosis. All patients (n ¼ 496) were followed up to month 18 and the overall results of the study have been reported previously. 3 
Patients
The study population comprised men and women aged 18-75 years with a clinical diagnosis of onychomycosis of the toenail, confirmed by positive mycological culture and microscopy (KOH examination) for a dermatophyte. Data on all patients belonging to the intention-to-treat population were included in the present analysis.
Analysis of prognostic factors of mycological cure at 72 weeks
Three separate multivariate analyses of mycological cure at 72 weeks were performed based on factors assessed at baseline, at week 12 and at week 24. The following prognostic variables were included in the univariate analysis based on baseline factors: patient's age, gender, weight, number of toenails involved, percentage of nail involvement, duration of infection, history of previous treatment and nature of study treatment.
The 12-week and 24-week prognostic factors included in the univariate and multivariate logistic regression analyses were length of nail growth, percentage change in nail involvement, direct KOH examination and mycological culture assessed at that particular time point.
Rationale and methods for statistical analysis
The effect of clinical and demographic factors at baseline on mycological cure at 72 weeks was assessed using a logistic regression model. The importance of a prognostic factor was assessed using the P-value of the Wald v 2 statistic and the odds ratio (OR) (risk in a given category as compared with the reference one) with its 95% confidence interval.
Results
Univariate and multivariate prognostic factor analyses of mycological cure at week 72 are presented in Table 1 . In the univariate prognostic factor analysis, none of the baseline clinical parameters had a statistically significant association with mycological cure at 72 weeks. Study treatment with terbinafine had a statistically significant positive effect on mycological cure at week 72 with an OR of 4AE03 after adjusting for all other baseline covariates. In the multivariate analysis, four prognostic factors appeared to be signi- ficantly associated with mycological cure at 72 weeks: positive culture at 12 weeks, positive microscopy and positive culture at 24 weeks were negatively associated with mycological cure at 72 weeks. Percentage change in nail involvement at week 24 was positively associated with mycological cure at 72 weeks although the magnitude of the association was small.
Discussion
Based on the assessment of mycology and the patient characteristics at baseline, we observed that a failure of onychomycosis to reach mycological cure at 72 weeks was associated with persistence of positive mycological culture at 12 and 24 weeks. In addition, positive direct microscopy at 24 weeks was associated with failure of onychomycosis to reach clinical cure. Of interest are the findings that none of the patient and disease characteristics at baseline seem to influence mycological cure at 72 weeks. Neither extent of nail involvement, number of toenails involved nor duration of disease was significantly associated with treatment outcome. However, we did not have information on the type of onychomycosis, the presence of a dermatophytoma or nail thickness. All these factors are thought to be important prognostic factors in the treatment of onychomycosis.
A recently published study 11 on the treatment of onychomycosis with itraconazole pulse therapy suggested that background factors, i.e. duration of onychomycosis, number of affected nails and severity of thickening of the nails had an influence on treatment outcome. This study included, however, a limited number of patients (n ¼ 63).
In the present study, of particular interest is the finding that positive culture at 12 weeks and direct microscopy or positive culture at 24 weeks is associated with treatment failure. The association at 24 weeks is stronger. Positive culture at 12 weeks and positive mycology at 24 weeks after start of treatment could become a prognostic tool to help evaluate the chance of cure of onychomycosis in patients treated with oral antifungal agents. This may help to identify difficult to treat patients for whom a more tailored treatment approach would be indicated.
